Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBTB18 (Zinc finger and BTB domain-containing protein 18) is a C2H2-type zinc finger transcription factor that acts as a transcriptional repressor essential for the proper timing of neural precursor differentiation and brain development, as well as myogenesis[1][2][3][4]. It recognizes specific DNA motifs and recruits chromatin remodeling complexes to target genes, directly suppressing proneurogenic factors like Pax6, Ngn2, and NeuroD1, ensuring exit from the cell cycle and maturation of neuronal progenitors. Pathogenic variants, particularly within its zinc finger domain, impair DNA binding and disrupt neural circuit formation, contributing to intellectual disability and other neurodevelopmental disorders. In cancer, ZBTB18 functions as a tumor suppressor—often silenced by promoter methylation in gliomas—where its functional loss is associated with enhanced proliferation and therapy resistance. ZBTB18 also has roles in chromatin organization and may participate in immune cell differentiation[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 18 (ZBTB18).